StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note published on Sunday. The firm issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Price Performance
Shares of Cumberland Pharmaceuticals stock opened at $1.20 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.44 and a quick ratio of 1.26. The company has a market cap of $16.92 million, a PE ratio of -1.56 and a beta of 0.22. The firm has a fifty day moving average price of $1.24 and a two-hundred day moving average price of $1.40. Cumberland Pharmaceuticals has a fifty-two week low of $1.07 and a fifty-two week high of $2.36.
Cumberland Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Cumberland Pharmaceuticals
- What Are Dividends? Buy the Best Dividend Stocks
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Bank Stocks – Best Bank Stocks to Invest In
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.